Loading...
OTCM
VSMD
Market cap0USD
Oct 29, Last price  
0.00USD
Name

Vasamed Inc

Chart & Performance

D1W1MN
OTCM:VSMD chart
P/E
0.00
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
1m
+29.66%
200,000100,0001,000,000134,1310687,5001,574,7962,123,8611,069,1391,386,294
Net income
-5m
L-23.88%
-9,400,000-11,300,000-11,800,000-7,785,276-5,302,178-3,400,022-1,852,506-2,281,119-6,421,851-4,888,153
CFO
-5m
L+18.06%
-8,800,000-11,900,000-10,800,000-6,413,007-3,357,397-1,204,524-2,235,993-1,639,396-3,953,196-4,667,005

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings. The company also provides advanced Wound Imaging & SmartDraw systems for precise wound measurement. Additionally, Vasamed offers the PAD-IQ Studycast, a platform that facilitates the rapid and secure transmission of diagnostic test results to vascular specialists. This enables prompt interpretation of findings and supports timely, medically indicated therapeutic interventions. For safeguarding its equipment, the company also supplies a custom carrying case for the PAD-IQ system. Vasamed caters to both clinicians and patients, and has been operating since its founding in 1988. Its corporate headquarters are located in Eden Prairie, Minnesota.
IPO date
Feb 14, 1996
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show